# US 2006/0069107 A1 · Method of treating behavioral disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0069107 A1
- Document ID: US20060069107A1
- Status: Published application
- Kind: A1
- Application number: 10/539,574
- Filed: 2003-12-24
- Published: 2006-03-30
- Earliest claimed: 2002-12-27
- Assignees: Kyowa Hakko Kogyo Co., Ltd.
- Inventors: Shizuo Shiozaki; Junichi Shimada; Hiroshi Kase; Mayumi Shindo
- Web page: https://patentgrep.com/patent/US20060069107A1

## CPC

- A61K 31/52: Purines, e.g. adenine
- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/02: for peripheral neuropathies
- A61P 25/14: for treating abnormal movements, e.g. chorea, dyskinesia
- A61P 25/20: Hypnotics; Sedatives
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a method of treating behavioral disorders such as attention deficit hyperactivity disorder, comprising administering an effective amount of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine or a pharmaceutically acceptable salt thereof to a patient in need thereof and the like.

## Claims

### Claim 1

A method of treating a behavioral disorder, comprising administering an effective amount of (E) -8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine or a pharmaceutically acceptable salt thereof to a patient in need thereof.

### Claim 2

Use of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine or a pharmaceutically acceptable salt thereof for manufacturing a therapeutic agent for the treatment of a behavioral disorder.

### Claim 3

A therapeutic agent for a behavioral disorder comprising (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine or a pharmaceutically acceptable salt thereof.

### Claim 4 (depends on 1)

The method of treating a behavioral disorder according to claim 1, wherein the behavioral disorder is attention deficit hyperactivity disorder.

### Claim 5 (depends on 2)

The use according to claim 2, wherein the behavioral disorder is attention deficit hyperactivity disorder.

### Claim 6 (depends on 3)

The therapeutic agent for treating a behavioral disorder according to claim 3, wherein the behavioral disorder is attention deficit hyperactivity disorder.

### Claim 7 (depends on 1)

The method of treating a behavioral disorder according to claim 1, wherein the behavioral disorder is Tic/Tourette's disorder.

### Claim 8 (depends on 2)

The use according to claim 2, wherein the behavioral disorder is Tic/Tourette's disorder.

### Claim 9 (depends on 3)

The therapeutic agent for treating a behavioral disorder according to claim 3, wherein the behavioral disorder is Tic/Tourette's disorder.
